from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2320c/rocE

LFCtreatmentdescriptionclass of inhibitor

-0.306

Amikacinug/mL Amikacintranslation

0.013

Cap5-10ug/mL Capreomycintranslation

-0.417

Rox10-50 ug/mL Roxithromycintranslation

-0.075

SM2-5 ug/mL Streptomycintranslation

0.541

Tet5-10 ug/mL Tetracyclinetranslation

0.410

Rif0.2-5ug/mL Rifampicintranscription

-0.374

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.914

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.987

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.258

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.123

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.554

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.802

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.735

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.768

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.147

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.832

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.070

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.125

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.211

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.123

KCN5-20 ug/mL Potassium cyaniderespiration

-1.189

NaN30.2-2 mM Sodium aziderespiration

0.257

Nigericin50 uM Nigericinrespiration

1.323

TRC10-150 ug/mL Triclosanrespiration

-0.149

TRZ10-25 ug/mL Thioridazinerespiration

0.870

Valinomycin0.5-10 uM Valinomycinrespiration

-2.932

ZnSO42 mM ZnSO4respiration

-0.467

menadione6-10 ug/mL Menadionerespiration

-0.561

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.655

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.325

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.716

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.045

NRP_1Non-replicating persistence stage 1dosRassociated

-0.179

Amp0.2mg/mL AmpicillincellWall

-0.567

Cephalexin20-100 ug/mL CephalexincellWall

-0.638

Cerulenin0.32-5 ug/mL CerulenincellWall

0.253

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.044

EMB10-20 ug/mL EthambutolcellWall

-0.570

Eta12-40 ug/mL EthionamidecellWall

-0.860

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.419

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.677

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.789

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.043

BZA0.12 mg/mL BenzamidearomaticAmides

0.508

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.125

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.284

H2O24 mM hydrogen peroxideDNAdamaging

-0.845

Levo10 ug/mL LevofloxacinDNAdamaging

0.289

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.436

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.620

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.263

UVUV-irradiationDNAdamaging

0.270

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.228

Antimycin12.5-50 ug/mL Antimycin A?

-0.434

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.428

PA_110-50 ug/mL Antitubercular compound PA-1?

0.382

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.266

PA8240.2-2 ug/mL PA-824?

0.930

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.221

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.857

Verapamil50 uM Verapamil?

-0.332

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.487

methoxatin10-20 ug/mL Methoxatin?